pI: 8.157 |
Length (AA): 301 |
MW (Da): 34809 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
7 | 301 | 1ym7 (A) | 167 | 475 | 26.00 | 0 | 1 | 1.26177 | -0.12 |
24 | 295 | 4af3 (A) | 70 | 338 | 43.00 | 0 | 1 | 1.37335 | -0.26 |
25 | 294 | 4c2v (A) | 87 | 353 | 40.00 | 0 | 1 | 1.46271 | -0.92 |
27 | 282 | 1o6l (A) | 148 | 410 | 34.00 | 0 | 1 | 1.2651 | -0.71 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127024)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G32830 | serine/threonine-protein kinase aurora-1 |
Brugia malayi | Bm1_12390 | serine/threonine protein kinase 6 |
Brugia malayi | Bm1_03120 | serine/threonine kinase 12 |
Brugia malayi | Bm1_15415 | serine/threonine-protein kinase 6 |
Candida albicans | CaO19.3474 | likely protein kinase similar to S. cerevisiae IPL1 (YPL209C) Aurora protein kinase involved in regulating kinetochore-microtubu |
Candida albicans | CaO19.10978 | likely protein kinase similar to S. cerevisiae IPL1 (YPL209C) Aurora protein kinase involved in regulating kinetochore-microtubu |
Caenorhabditis elegans | CELE_B0207.4 | Protein AIR-2 |
Cryptosporidium hominis | Chro.20335 | protein kinase (EC 2.7.1.-) p46XlEg22 |
Cryptosporidium parvum | cgd2_3190 | protein kinase, putative |
Dictyostelium discoideum | DDB_G0279343 | Aurora family protein kinase |
Drosophila melanogaster | Dmel_CG3068 | aurora |
Drosophila melanogaster | Dmel_CG6620 | IplI-aurora-like kinase |
Echinococcus granulosus | EgrG_001059700 | aurora kinase A |
Echinococcus granulosus | EgrG_000891900 | serine:threonine protein kinase 12 B |
Entamoeba histolytica | EHI_177010 | serine/threonine- protein kinase 6 , putative |
Entamoeba histolytica | EHI_193840 | protein kinase , putative |
Entamoeba histolytica | EHI_033850 | serine/threonine- protein kinase 6, putative |
Entamoeba histolytica | EHI_011220 | protein kinase, putative |
Entamoeba histolytica | EHI_071320 | protein kinase, putative |
Entamoeba histolytica | EHI_104940 | serine/threonine protein kinase 6, putative |
Entamoeba histolytica | EHI_142710 | protein kinase domain containing protein |
Echinococcus multilocularis | EmuJ_001059700 | aurora kinase A |
Echinococcus multilocularis | EmuJ_000891900 | serine:threonine protein kinase 12 B |
Giardia lamblia | GL50803_5358 | Aurora kinase |
Homo sapiens | ENSG00000178999 | aurora kinase B |
Homo sapiens | ENSG00000087586 | aurora kinase A |
Homo sapiens | ENSG00000105146 | aurora kinase C |
Leishmania braziliensis | LbrM.28.0540 | protein kinase, putative |
Leishmania donovani | LdBPK_280550.1 | Aurora I-related kinase |
Leishmania infantum | LinJ.28.0550 | protein kinase, putative |
Leishmania major | LmjF.28.0520 | protein kinase, putative |
Leishmania mexicana | LmxM.28.0520 | protein kinase, putative |
Loa Loa (eye worm) | LOAG_02905 | AUR protein kinase |
Loa Loa (eye worm) | LOAG_01615 | AUR protein kinase |
Loa Loa (eye worm) | LOAG_03125 | AUR protein kinase |
Mus musculus | ENSMUSG00000027496 | aurora kinase A |
Mus musculus | ENSMUSG00000070837 | aurora kinase C |
Mus musculus | ENSMUSG00000020897 | aurora kinase B |
Neospora caninum | NCLIV_021920 | hypothetical protein |
Oryza sativa | 4327302 | Os01g0191800 |
Plasmodium berghei | PBANKA_0407400 | serine/threonine protein kinase, putative |
Plasmodium falciparum | PF3D7_0309200 | serine/threonine protein kinase, putative |
Plasmodium knowlesi | PKNH_0833500 | serine/threonine protein kinase, putative |
Plasmodium vivax | PVX_119575 | serine/threonine protein kinase 6, putative |
Plasmodium yoelii | PY03456 | putative protein kinase |
Plasmodium yoelii | PY03956 | Protein kinase domain, putative |
Saccharomyces cerevisiae | YPL209C | aurora kinase |
Schistosoma japonicum | Sjp_0046880 | ko:K08850 aurora kinase, putative |
Schistosoma japonicum | Sjp_0093670 | Serine/threonine-protein kinase 12, putative |
Schistosoma mansoni | Smp_162710 | protein kinase |
Schistosoma mansoni | Smp_135360 | serine/threonine protein kinase |
Schmidtea mediterranea | mk4.000743.05 | Serine/threonine-protein kinase flr-4 |
Schmidtea mediterranea | mk4.005195.01 | Aurora kinase-2 |
Schmidtea mediterranea | mk4.006705.00 | Aurora/Ipl1-related protein kinase 1 |
Schmidtea mediterranea | mk4.008584.00 | EG:8D8.5 protein |
Schmidtea mediterranea | mk4.008598.01 | Aurora kinase-1 |
Schmidtea mediterranea | mk4.000916.10 | Serine/threonine-protein kinase flr-4 |
Schmidtea mediterranea | mk4.014531.00 | Aurora kinase-2 |
Schmidtea mediterranea | mk4.006705.01 | Protein kinase |
Schmidtea mediterranea | mk4.034612.00 | Aurora/IPL1-related protein kinase 2 |
Schmidtea mediterranea | mk4.005195.02 | Aurora/IPL1-related protein kinase 2 |
Schmidtea mediterranea | mk4.011981.00 | Aurora/IPL1-related protein kinase 2 |
Schmidtea mediterranea | mk4.016831.00 | |
Trypanosoma brucei gambiense | Tbg972.11.9400 | protein kinase, putative |
Trypanosoma brucei | Tb927.11.8220 | aurora B kinase |
Trypanosoma congolense | TcIL3000.11.8760 | aurora B kinase |
Trypanosoma cruzi | TcCLB.508817.80 | aurora B kinase, putative |
Toxoplasma gondii | TGME49_203010 | aurora kinase |
Trichomonas vaginalis | TVAG_300450 | AGC family protein kinase |
Trichomonas vaginalis | TVAG_030770 | AGC family protein kinase |
Trichomonas vaginalis | TVAG_475150 | AGC family protein kinase |
Trichomonas vaginalis | TVAG_050080 | AGC family protein kinase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.0330 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.0330 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.0330 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.0330 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_B0207.4 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_B0207.4 | Caenorhabditis elegans | sterile | wormbase |
YPL209C | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_0407400 | Plasmodium berghei | Essential | plasmo |
TGME49_203010 | Toxoplasma gondii | Essentiality uncertain | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | aurora kinase C | Compounds | References |
Xenopus laevis | Aurora kinase B-A | Compounds | References |
Mus musculus | aurora kinase B | Compounds | References |
Homo sapiens | aurora kinase A | Compounds | References |
Xenopus laevis | Aurora kinase B-B | Compounds | References |
Homo sapiens | aurora kinase B | Compounds | References |
Mus musculus | aurora kinase A | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Rattus norvegicus | Cell division protein kinase 5 | 292 aa | 26.3% | 297 aa | Compounds | References |
Plasmodium falciparum (isolate 3D7) | Cell division control protein 2 homolog | 288 aa | 24.2% | 293 aa | Compounds | References |
Patiria pectinifera | Cdc2 | 300 aa | 25.6% | 293 aa | Compounds | References |
Homo sapiens | Cyclin-dependent kinase 1/cyclin B1 | 297 aa | 25.3% | 293 aa | Compounds | References |